A validation study of the Focalpoint GS imaging system for gynecologic cytology screening
Version of Record online: 10 JUL 2013
© 2013 American Cancer Society
Volume 121, Issue 12, pages 737–738, December 2013
How to Cite
Renshaw, A. and Elsheikh, T. M. (2013), A validation study of the Focalpoint GS imaging system for gynecologic cytology screening. Cancer Cytopathology, 121: 737–738. doi: 10.1002/cncy.21336
- Issue online: 13 DEC 2013
- Version of Record online: 10 JUL 2013
- 3US Food And Drug Administration. How Laboratorians Can Safely Calculate Workload for FDA-Approved Semi-Automaed Gynecologic Cytology Screening Devices. Washington, DC: US Food and Drug Administration; 2010. fda.gov/MedicalDevices/Safety/AlertsandNotices/TipsandArticlesonDeviceSafety/ucm220292.htm. Accessed May 1, 2013.
- 11American Society of Cytopathology Workload recommendations for automated Pap test screening: developed by the productivity and quality assurance in the era of automated screening task force. Diagn Cytopathol. 2013;41:174-178., , , , , .